Exact Mass: 287.982
Exact Mass Matches: 287.982
Found 224 metabolites which its exact mass value is equals to given mass value 287.982,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Triclosan
Triclosan is an antibacterial and antifungal agent. It is a polychloro phenoxy phenol. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. According to the Food and Drug Administration (FDA) at the present time there is no evidence that triclosan in personal care products provides an extra benefit to health beyond its anti-gingivitis effect in toothpaste. The FDA does not recommend changing consumer use of triclosan containing products one way or the other due to currently insufficient safety evidence. Studies by the Environmental Protection Agency (EPA) found triclosan to be an effective antibacterial. Triclosan safety is currently under review by the FDA and Health Canada. Triclosan is only found in individuals that have used or taken this drug. D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AE - Phenol and derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8632 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8246 CONFIDENCE standard compound; EAWAG_UCHEM_ID 168 D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents C254 - Anti-Infective Agent
3-deoxy-D-arabino-heptulosonate-7-phosphate
2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate, also known as 2-dahp or 3-deoxy-arabino-heptulonic acid 7-phosphoric acid, is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate is soluble (in water) and a moderately acidic compound (based on its pKa). 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate can be found in a number of food items such as prairie turnip, horned melon, bilberry, and biscuit, which makes 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate a potential biomarker for the consumption of these food products. 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate exists in E.coli (prokaryote) and yeast (eukaryote).
5'-(3',4'-Dihydroxyphenyl)-gamma-valerolactone sulfate
5-(3,4-dihydroxyphenyl)-gamma-valerolactone sulfate is a cocoa metabolite from gut microflora. It is found in urine.
5-(3',4'-Dihydroxyphenyl)-γ-valerolactone 4'-sulfate
5-(3',5'-Dihydroxyphenyl)-γ-valerolactone sulfate
Ciprofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D009676 - Noxae > D002273 - Carcinogens > D020025 - Peroxisome Proliferators D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].
Dodecafluoropentane
V - Various > V08 - Contrast media > V08D - Ultrasound contrast media > V08DA - Ultrasound contrast media C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline
Ciprofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D009676 - Noxae > D002273 - Carcinogens > D020025 - Peroxisome Proliferators D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4943; ORIGINAL_PRECURSOR_SCAN_NO 4941 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4958; ORIGINAL_PRECURSOR_SCAN_NO 4954 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4923; ORIGINAL_PRECURSOR_SCAN_NO 4921 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4952; ORIGINAL_PRECURSOR_SCAN_NO 4949 ORIGINAL_ACQUISITION_NO 4951; CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 4949 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4951; ORIGINAL_PRECURSOR_SCAN_NO 4949 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4945; ORIGINAL_PRECURSOR_SCAN_NO 4943 Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].
4,10-Dihydroxy-6-methylfuro[3,4:6,7]naphtho[2,3-d]-1,3-dioxole-5,9-dione
2-acetoxymethyl-5--bithienyl(2,5)|5-Acetoxymethyl-2--dithienyl-(5,2)|5-acetoxymethyl-5-(3-butene-1-ynyl)-2,2-bithiophene|5-(3-Buten-1-ynyl)-2,2-bithienyl-5-methylacetate|5-Acetoxymethyl-5-but-3-en-1-inyl-<2,2>-bithienyl|5-acetoxymethyl-5-but-3-en-1-ynyl-[2,2]bithiophenyl
7,8-dihydroxy-3-(3-hydroxy-4-oxo-4H-pyran-2-yl)-2H-chromen-2-one
2,7-Naphthalenedisulfonic acid
CONFIDENCE standard compound; INTERNAL_ID 8677 CONFIDENCE standard compound; EAWAG_UCHEM_ID 654
5-(3,4-Dihydroxyphenyl)-gamma-valerolactone sulfate
(5-(but-3-en-1-yn-1-yl)-[2,2-bithiophen]-5-yl)methyl acetate
4(1H)-Quinazolinone,3-(4-chlorophenyl)-2,3-dihydro-2-thioxo-
4-(4-CHLORO-PHENYL)-5-PYRIDIN-4-YL-4H-[1,2,4]TRIAZOLE-3-THIOL
5-chloro-3-[[ethoxy(methyl)phosphoryl]methyl]-1-benzothiophene
phenyl N-[4-(trifluoromethyl)-1,3-thiazol-2-yl]carbamate
Methyl 4-bromo-7-methoxybenzo[d][1,3]dioxole-5-carboxylate
3-((4-CHLOROPHENYL)SULFONYL)-4-ETHOXYBUT-3-EN-2-ONE
4-Chloro-6-acetoxy-7-methoxyquinazoline hydrochloride
2,6-diamino-4-(4-chlorophenyl)-4H-thiopyran-3,5-dicarbonitrile
1-Benzyl-2-(bromodifluoromethyl)-4,5-dihydro-1H-imidazole
Benzoic acid, 2-[(1E)-2-iodoethenyl]-, methyl ester
ETHYL 2-BROMO-4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE-3-CARBOXYLATE
(5-Bromo-3-nitropyridin-2-yl)acetic acid ethyl ester
potassium (3,5-dinitro-2-methylphenyl)trifluoroborate
4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)benzoic acid
2-(2,4-dichloro-5-nitrophenyl)-5-methyl-1H-1,2,4-triazol-3-one
3-CHLORO-4-([5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY)ANILINE
5-[(4-bromo-3,5-dimethylpyrazol-1-yl)methyl]-3H-1,3,4-oxadiazole-2-thione
2-CHLORO-6-(2-THIENYL)-4-(TRIFLUOROMETHYL)NICOTINONITRILE
Thiazolidine, 3-(methylsulfonyl)-2-(3-nitrophenyl)- (9CI)
Thiazolidine, 3-(methylsulfonyl)-2-(4-nitrophenyl)- (9CI)
N-(6-bromo-7-oxo-5,6-dihydro-4H-1,3-benzothiazol-2-yl)acetamide
4(1H)-Quinazolinone,3-(3-chlorophenyl)-2,3-dihydro-2-thioxo-
2-mercapto-5-benzimidazolesulfonic acid sodium salt dihydrate
2-(5,6-dichloro-4-methylsulfanylpyridin-3-yl)-5-ethyl-1,3-oxazole
3-chloro-5-[(3-methoxyphenyl)methylsulfinyl]-1,2,4-thiadiazole
2-bromo-3,3,3-trifluoro-1-(4-methylpiperazin-1-yl)propan-1-one
2,6-diamino-4-(2-chlorophenyl)-4H-thiopyran-3,5-dicarbonitrile
1,3-Benzodioxole-5-carboxylic acid, 6-bromo-7-methoxy-, methyl ester
5-Bromo-1-butyl-1H-benzo[d]imidazole hydrochloride
3-[6-(2-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
3-[6-(3-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
3-[6-(4-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
3-chloro-5-[(4-methylphenyl)methylsulfonyl]-1,2,4-thiadiazole
1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-QUINAZOLINE-6-SULFONYL CHLORIDE
BENZENEBUTANOIC ACID, 2,4-DICHLORO-.ALPHA.,.GAMMA.-DIOXO-, ETHYL ESTER
3-(2-CHLORO-PHENYL)-2-MERCAPTO-3H-QUINAZOLIN-4-ONE
1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone
methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-fluorophenyl)penta-2,4-dienoate
4,5-dichloro-2-[(4-chlorophenyl)methyl]pyridazin-3-one
2,6-DICHLORO-4-(TRIFLUOROMETHOXY)PHENYLACETIC ACID
Ethyl 2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-1-ene-1-carboxylate
1-(trichloromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
Methyl 5-{[(5-sulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}furan-2-carboxylate
triclosan
D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AE - Phenol and derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents C254 - Anti-Infective Agent
dodecafluoropentane
V - Various > V08 - Contrast media > V08D - Ultrasound contrast media > V08DA - Ultrasound contrast media C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent
[5-(5-But-3-en-1-ynylthiophen-2-yl)thiophen-2-yl]methyl acetate
D-Sedoheptulose 7-phosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Carboxy-2-deoxy-alpha-D-glucopyranose 6-phosphoric acid
5-(3,5-Dihydroxyphenyl)-gamma-valerolactone sulfate
[4-[(Z)-2-hydroxy-3-oxobut-1-enyl]-2-methoxyphenyl] hydrogen sulate
[4-(3-Acetyloxiran-2-yl)-2-methoxyphenyl] hydrogen sulate
(2xi)-3-deoxy-7-O-phospho-beta-D-threo-hept-6-ulopyranosonic acid
[4-[(E)-4-hydroxy-3-oxobut-1-enyl]-2-methoxyphenyl] hydrogen sulfate
3-deoxy-D-arabino-heptulosonate-7-phosphate
A ketoaldonic acid phosphate consisting of 2-dehydro-3-deoxy-D-arabino-heptonic acid having a phospho group at the 7-position.
D-glycero-beta-D-manno-heptose 1-phosphate(2-)
D-glycero-D-manno-heptose 1-phosphate(2-) with beta-configuration at the anomeric carbon atom.
sedoheptulose 7-phosphate(2-)
An organophosphate oxoanion that is the dianion of sedoheptulose 7-phosphate arising from deprotonation of both OH groups from the phosphate.
D-glycero-alpha-D-manno-heptose 1-phosphate(2-)
D-glycero-D-manno-heptose 1-phosphate(2-) with alpha-configuration at the anomeric carbon atom.
D-glycero-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-D-manno-heptose 7-phosphate.
2-Hydroxy-5-[(5-oxooxolan-2-yl)methyl]phenyl hydrogen sulfate
D-glycero-D-manno-heptose 1-phosphate(2-)
Dianion of D-glycero-D-manno-heptose 1-phosphate arising from deprotonation of both phosphate OH groups.
5-(3,4-dihydroxyphenyl)-gamma-valerolactone 3-O-sulfate
A butan-4-olide that is gamma-valerolactone in which one of the methyl hydrogens has been replaced by a 3-sulfooxy-4-hydroxyphenyl group.
D-glycero-alpha-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-alpha-D-manno-heptose 7-phosphate.
D-glycero-beta-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-beta-D-manno-heptose 7-phosphate.
[5'-(but-3-en-1-yn-1-yl)-[2,2'-bithiophen]-5-yl]methyl acetate
(3e)-4-(2,6-dichloro-3,5-dimethoxyphenyl)pent-3-en-2-one
{2-methoxy-4-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl}oxidanesulfonic acid
5-(3-buten-1-ynyl)-2,2'-bithienyl-5'-methylacetate
{"Ingredient_id": "HBIN011008","Ingredient_name": "5-(3-buten-1-ynyl)-2,2'-bithienyl-5'-methylacetate","Alias": "NA","Ingredient_formula": "C15H12O2S2","Ingredient_Smile": "CC(=O)OCC1=CC=C(S1)C2=CC=C(S2)C#CC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-(3-buten-1-ynyl)-2,2'-bithienyl-5’-methyl-acetate
{"Ingredient_id": "HBIN011009","Ingredient_name": "5-(3-buten-1-ynyl)-2,2'-bithienyl-5\u2019-methyl-acetate","Alias": "NA","Ingredient_formula": "C15H12O2S2","Ingredient_Smile": "CC(=O)OCC1=CC=C(S1)C2=CC=C(S2)C#CC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14526","TCMID_id": "2784","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
